EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 210 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $191,083 | -53.7% | 56,201 | 0.0% | 0.00% | – |
Q2 2023 | $413,077 | +28969.5% | 56,201 | -59.0% | 0.00% | -100.0% |
Q1 2023 | $1,421 | -19.1% | 137,195 | -7.7% | 0.00% | 0.0% |
Q4 2022 | $1,757 | -100.0% | 148,701 | -21.3% | 0.00% | 0.0% |
Q3 2022 | $3,589,000 | -33.2% | 188,876 | +9.2% | 0.00% | -50.0% |
Q2 2022 | $5,371,000 | -27.0% | 173,040 | -16.4% | 0.00% | 0.0% |
Q1 2022 | $7,359,000 | -13.7% | 207,007 | +5.5% | 0.00% | -33.3% |
Q4 2021 | $8,529,000 | -19.4% | 196,204 | -24.3% | 0.00% | 0.0% |
Q3 2021 | $10,588,000 | -48.4% | 259,038 | -20.5% | 0.00% | -50.0% |
Q2 2021 | $20,532,000 | -45.7% | 325,959 | -28.0% | 0.01% | -50.0% |
Q1 2021 | $37,817,000 | +15.5% | 452,784 | +23.9% | 0.01% | +9.1% |
Q4 2020 | $32,739,000 | +1.8% | 365,390 | +17.4% | 0.01% | -8.3% |
Q3 2020 | $32,167,000 | +43.5% | 311,303 | +9.8% | 0.01% | +33.3% |
Q2 2020 | $22,418,000 | +45.2% | 283,482 | +6.3% | 0.01% | +12.5% |
Q1 2020 | $15,437,000 | +21.6% | 266,796 | +13.4% | 0.01% | +60.0% |
Q4 2019 | $12,696,000 | +29.6% | 235,315 | +25.6% | 0.01% | +25.0% |
Q3 2019 | $9,797,000 | +1.0% | 187,403 | -6.7% | 0.00% | 0.0% |
Q2 2019 | $9,704,000 | +523.2% | 200,846 | +551.5% | 0.00% | -50.0% |
Q1 2019 | $1,557,000 | +8.2% | 30,828 | +27.0% | 0.01% | -11.1% |
Q4 2018 | $1,439,000 | -38.9% | 24,283 | -32.2% | 0.01% | -30.8% |
Q3 2018 | $2,357,000 | -16.0% | 35,799 | -35.6% | 0.01% | -27.8% |
Q2 2018 | $2,807,000 | +1.6% | 55,601 | +6.0% | 0.02% | 0.0% |
Q1 2018 | $2,763,000 | +26.3% | 52,476 | +11.4% | 0.02% | +28.6% |
Q4 2017 | $2,188,000 | -2.5% | 47,089 | -15.1% | 0.01% | -6.7% |
Q3 2017 | $2,243,000 | -7.5% | 55,454 | -22.4% | 0.02% | -6.2% |
Q2 2017 | $2,424,000 | +30.0% | 71,473 | +11.4% | 0.02% | +45.5% |
Q1 2017 | $1,864,000 | -5.0% | 64,187 | +7.4% | 0.01% | +10.0% |
Q4 2016 | $1,962,000 | +0.1% | 59,747 | -3.9% | 0.01% | -9.1% |
Q3 2016 | $1,960,000 | +18.2% | 62,148 | +5.4% | 0.01% | +10.0% |
Q2 2016 | $1,658,000 | -24.8% | 58,959 | -2.8% | 0.01% | -16.7% |
Q1 2016 | $2,206,000 | -4.8% | 60,685 | +4.8% | 0.01% | 0.0% |
Q4 2015 | $2,317,000 | +64.9% | 57,900 | +17.4% | 0.01% | +50.0% |
Q3 2015 | $1,405,000 | +106.6% | 49,314 | +139.0% | 0.01% | +100.0% |
Q2 2015 | $680,000 | – | 20,633 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |